Dec
5
10:00 AM10:00

$80K Pitch Competition on December 5, 2024.

  • Mansfield Bio-Incubator, Inc. (map)
  • Google Calendar ICS

Join us for the Pitch Competition, an exciting day of life science innovation, networking and opportunity.

⏰ When: December 5th, 2024, 10 AM - 2 PM.

📍 Where: Mansfield Bio-Incubator, 241 Francis Ave Mansfield, MA 02048

🌟 Featured: Handpicked start-ups companies in biotech, pharma, medtech, life sciences, and cleantech.

Therapeutics:

Neuronity Therapeutics– Revolutionizing the treatment of neurological disorders by restoring the immune system in the aging brain.

PhagePro – Solving global health disparities by harnessing the therapeutic potential of phages.

Otrera Medical – Developing treatments for antidepressant-induced female sexual dysfunction.

Pending AI – Designing higher-quality medicines with scalable AI and quantum mechanics.

Trivoke Therapeutics – Engaging innate and adaptive immunity for immediate tumor control and lasting cancer defense.

Alnivo Therapeutics – Unlocking the therapeutic potential of HSP70 in tissue regeneration and repair.

Diagnostics:

Aged Diagnostics – The first accurate blood test for liver disease.

Emitech – Revolutionizing the opioid testing industry with a supremely convenient, sensitive, and cost-effective test.

Stapgen – Pioneering diagnostic and treatment technology for the prevention of Type 2 Diabetes.

Advanced Materials:

Unsmudgeable – Green fingerprint-fading eyewear coating for a lifetime of clear vision.

Food as Medicine:

UpLevel Foods – Reducing risk and improving health with high functional impact foods.

👥 Attending: Investors, entrepreneurs, mentors, life science professionals, business development experts, sponsors.

🔍 Why attend:

§ Learn about innovations that will revolutionize healthcare

§ Explore investment opportunities

§ Network with industry veterans and the new generation shaping the future of life sciences

§ Showcase your products and services to a targeted audience of professionals and stakeholders

The Prizes Are:

1st Place: $37K ($12K cash + 10 months of lab space)

2nd Place: $23K ($8K cash + 6 months of lab space)

3rd Place: $14K ($4K cash + 4 months of lab space)

Special prizes will be revealed closer to the event.

We invite you to check out the video of our past competition here.

We look forward to seeing you in Mansfield. Please feel free to share this information with your colleagues.

Agenda:

9:00 - 10:00: Breakfast, Networking, Registration

10:00 - 10:20: Welcoming Remarks

10:20 - 11:10: Company Presentations

11:10 -11:15: Mentoring Program Graduation Ceremony (Fall 2024 Cohort)

11:15 - 12:00: Lunch, Networking, Tours

12:00 - 1:00: Company Presentations

1:00 -1:30: Judges’ Deliberations, Networkiing

1:30 - 1:45: Awards Ceremony

1:45 - 1:50: Concluding Remarks

View Event →
Oct
22
5:00 PM17:00

A Book Discussion: Bumbling Through the Hindu Kush: A Memoir of Fear and Kindness in Afghanistan By Chris Woolf

  • Mansfield Bio-Incubator, Inc. (map)
  • Google Calendar ICS

Mansfield Bio-Incubator is inviting you to the book discussion and a networking event.

Where: Mansfield Bio-Incubator 241 Francis Ave Mansfield, MA 02048

When: Tuesday, October 22, 2024.

Doors open at 5 PM, the discussion will start at 6 PM.

Refreshments will be served

Bumbling Through the Hindu Kush:

 A Memoir of Fear and Kindness in Afghanistan

By Chris Woolf

[Publication date 4 Oct 2021] 

AVAILABLE IN PAPERBACK; KINDLE E-BOOK; AUDIOBOOK (NARRATED BY THE AUTHOR)

A Brief Synopsis: What happens when a regular person accidentally finds themselves lost in the middle of a war? In 1991, Chris Woolf travelled to Afghanistan to visit a BBC colleague. They hitched a ride with an aid convoy and bumbled straight into the war.

About the Author:

Chris Woolf was a broadcast journalist with the BBC World Service for 34 years. He worked mostly in the United States, where he became News Editor for public radio’s main international news show, “The World.” He was also on-air as the show’s “History Guy.”

View Event →
Leveraging the use of AI in business. A concise brief.
Jun
12
10:00 AM10:00

Leveraging the use of AI in business. A concise brief.

  • Mansfield Bio-Incubator, Inc. (map)
  • Google Calendar ICS

If you are starting or growing a business or are a business leader, you have questions, and we have answers.

Here are some major burning questions:

  • Do you get the feeling that we are in an AI revolution?

  • And if it's been around since the 1950s, what’s all the fuss now? 

  • Becoming an AI-powered organization sounds cool, so why should I be one?  

  • What can AI do to help me to start or grow my business? How about some real examples? 

  • What are the best business functions to leverage AI tools? 

  1. Internally: Product design, HR, Marketing, Sales, IT, Finance, Operations, Regulatory, Clinical trials 

  2. Externally: Business development, Prospecting, Marketing, Investors and Funding 

  • How do I learn more?   

Start by attending this free executive event, which will provide examples of how companies are leveraging AI to make a positive, meaningful impact on their businesses.   

Who should attend: Entrepreneurs, especially in life science/healthcare/cleantech.

Guest speaker: Joel Evans,  A tech leader who speaks human, Founder & Managing Partner Emerging Technology Innovators, Inc.

Where: Hybrid session. In-person at the Mansfield Bio-Incubator and on-line via ZOOM  

View Event →
PurCell Bio Reception Ceremony at Mansfield Bio-Incubator
May
22
4:00 PM16:00

PurCell Bio Reception Ceremony at Mansfield Bio-Incubator

Dear PurCell Bio stockholders, business partners, friends, potential investors, customers, and colleagues,

We are thrilled to announce our new tenancy at the Mansfield BioIncubator! We cordially invite you to join us in celebrating this significant milestone in our journey of progress and growth.

Please mark your calendars for the PurCell Bio reception ceremony, scheduled for May 22nd between 4-6pm EST.

Address:

PurCell Bio, Inc.

Mansfield Bio-Incubator

241 Francis Ave

Mansfield, MA 02048

Website: www.purcell-bio.com

LinkedIn: https://www.linkedin.com/company/purcell-bio/

Mansfield BioIncubator Home Page: https://www.bioinc.org/

Directions: https://www.bioinc.org/location-transit-1

We look forward to your presence and sharing this momentous occasion with you.

Warm regards,

Henry

Henry Lisoukov, MBA

Director of Business Development

PurCell Bio, Inc.

Business: (406) 206-3004

Cell: (508) 840-9269 Email: hlisoukov@purcell-bio.com

Website: www.purcell-bio.com

LinkedIn: https://www.linkedin.com/company/purcell-bio/

View Event →
$20K Pitch Competition
May
21
9:00 AM09:00

$20K Pitch Competition

Join us for the Mansfield Pitch Competition, an exciting day of life science innovation, networking and opportunity.

⏰ When: May 21, 2024, 9 AM - 3 PM.

📍 Where: Mansfield Bio-Incubator, 241 Francis Ave Mansfield, MA 02048

🌟 Featured: 14 handpicked start-ups (see the list below) representing therapeutics (oncology, diabetes, Parkinson's), medical devices (women's health, smudge-proof glasses, opioid detection), diagnostics (cervical cancer) and biotechnology (bio tools, genetic diseases, tissue engineering).

In addition, there will be a graduation ceremony for the Spring 2024 Mentoring Program cohort consisting of three presenting startups (Neuronity Therapeutics, Emitech, and Unsmudgeable).

👥 Attending: Investors, entrepreneurs, mentors, life science professionals, business development experts, sponsors

🔍 Why attend:

§ Learn about innovations that will revolutionize healthcare

§ Explore investment opportunities

§ Network with industry veterans and the new generation shaping the future of life sciences

§ Showcase your products and services to a targeted audience of professionals and stakeholders

The Prizes Are:

$20,000 for first place;

$12,000 for second place;

$8,000 for third place.

We look forward to seeing you in Mansfield. Please feel free to share this information with your colleagues.

Agenda:

9:00 am - 10:00 am: Doors Open, Breakfast and Networking

10:00 am -10:05 am: Opening Remarks, Russ Yukhananov, President, Mansfield Bio-Incubator

10:05 am -10:10 am: Christopher McDermott, Director of Economic Development, Town of Mansfield

10:10 am -10:15 am: Rep. Jay Barrows (R), Massachusetts House of Representatives, 1st Bristol

10:15 am -10:20 am: Sarah Stanton, Undersecretary of Economic Strategies, Executive Office of Housing and Economic Development (EOHED), Commonwealth of Massachusetts

10:20 am -10:25 am: Introduction to the Pitch Competition, Alex Shlyankevich, Investor Relations Director, Mansfield Bio-Incubator

10:25 am -11:25 am: Company Presentations

11:25 am -11:40 am: Mentoring Program Graduation Ceremony (Spring 2024 Cohort)

11:40 am -12:30 pm: Lunch, Networking, Tour of Mansfield Bio-Incubator

12:30 pm - 1:40 pm: Company Presentations

1:40 pm - 2:10 pm: Judges' Deliberations, Networking

2:10 pm - 2:25 pm: Award Ceremony

2:25 pm - 2:30 pm: Concluding Remarks, Alexander Margulis, Chief Operating Officer, Mansfield Bio-Incubator

CONTESTANTS

Therapeutics

1. Neuronity Therapeutics – Revolutionizing the treatment of neurological disorders by restoring a healthy immune system in the aging brain.

2. Opprtna Therapeutics – Empowering health through precision aptamer therapeutics.

3. Manhattan BioSolutions – Next-generation precision biologics that harness the power of host defense adaptations to transform cancer treatment paradigms.

4. Guardian Bio – Next-generation dendritic cell therapy for solid tumors utilizing newly discovered cDC1 subtype with the first clinical trial planned in melanoma.

5. Palate Therapeutics – Revolutionizing metabolic health by targeting taste buds.

6. Therabene – First-in-class targeted therapies for the cure of hard-to-treat lung, pancreatic, and triple-negative breast cancer.

Diagnostics and Devices

7. 3Daughters – Evolutionary healthcare for women with a novel targeted uterine delivery platform to address the neglected problem of IUD insertion pain.

8. Lilypad Health – At-home non-invasive menstrual blood screening tool for gynecological diseases and biomarkers such as HPV, STDs, and fertility hormones.

9. Emitech – Revolutionizing the drug testing industry with an exceptionally convenient, accurate, and cost-effective test.

10. Unsmudgeable – A green permanent anti-smudge lens coating for a lifetime of clear vision that improves safety, productivity, and comfort.

Biotechnology Enablers

11. PurCell Bio – Meticulously engineered, animal-free cell culture media systems to meet the evolving needs of advanced biotechnologies.

12. DINYA DNA – Enabling innovation in the life sciences with the next generation of gene synthesis.

13. 100XBIO – Automated platform for multiplex T-cell analysis.

Key Sponsors and Partners

View Event →
MLSC MassNextGen Info Session
May
7
11:00 AM11:00

MLSC MassNextGen Info Session

Please join us to learn how the MLSC supports diverse entrepreneurs and early-stage life science companies through MassNextGen and other initiatives.

Optional networking after the session.

The MassNextGen Initiative is a public-private partnership between the MLSC and our corporate sponsors, Takeda, Bristol Myers Squibb, Johnson & Johnson Innovation, Mintz, Berkshire Innovation Center, Cambridge Scientific Labs, InnoVenture Labs, Massachusetts Biomedical Initiatives, M2D2, and Mansfield Bio-Incubator.

View Event →
Analytica 2024 Conference, Munich, Germany
Apr
9
to Apr 12

Analytica 2024 Conference, Munich, Germany

Mansfield Bio-Incubator will exhibit at Analytica 2024, World's Leading Trade Fair for laboratory technology, analysis, biotechnology and analytica conference in Munich, Germany .

Come visit us at Booth 232, Hall A3 to learn about why Mansfield Bio-Incubator would be an ideal partner for the life science companies looking to establish the presence in the USA, less than 1 hour from Boston/Cambridge, the top life science cluster in the world.

Dr. Alex Margulis, Mansfield Bio-Incubator’s COO, will be presenting on April 12, 2024 at 10:30 AM at Hall A3/527 Startup support and creation: BioIncubator and Accelerators to stimulate growth and startup creation.

View Event →
An Inside Look at the NIH SBIR Proposal Submission and Review Process.
Jan
25
10:00 AM10:00

An Inside Look at the NIH SBIR Proposal Submission and Review Process.

  • Mansfield Bio-Incubator, Inc. (map)
  • Google Calendar ICS

You are invited to learn about some of the intricacies of the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) funding mechanism, proposal submissions, and their evaluation process. Our speaker, Jason D. Harry, PhD, is the Hugh W. Pearson '58 Professor of the Practice of Technology and Entrepreneurship in the School of Engineering at Brown University. He has recently served on an NIH SBIR scientific review panel, and in prior medical device startups received significant NIH SBIR funding. He will shed light on the procedures involved in the NIH SBIR proposal review process, offering valuable insights to researchers, scientists, and anyone interested in understanding the dynamics of securing SBIR funding in the field of life sciences.

Agenda:

Introduction: Key aspects of SBIR proposals.

Overview of NIH SBIR Review Process: Overview of the various stages of the SBIR review process at the NIH.

Insights into Evaluation Criteria: Highlight the specific criteria used by NIH reviewers to assess the scientific merit, feasibility, and potential impact of proposed research projects.

Q&A Session: Following the talk, attendees will have the opportunity to engage in a brief question and answer session, facilitating a deeper understanding of the topics discussed.

This event promises to be a unique opportunity to gain firsthand knowledge about the inner workings of life science grant submissions at the NIH. Whether you are an early-career researcher navigating the grant application process or an established scientist seeking to refine your approach, this talk is sure to provide valuable insights that can enhance your grant-writing skills.

We look forward to your participation in this enlightening discussion on the critical processes that shape the landscape of life science SBIR funding.

View Event →
Size does not matter — get answers to your challenging analytical questions for all molecule types 
Mar
21
11:00 AM11:00

Size does not matter — get answers to your challenging analytical questions for all molecule types 

SCIEX & Phenomenex LC-MS Lunch & Learn Seminar

Tuesday, March 21st                                                                                                    

11:00 a.m. – 1:00 p.m.                                                                                                     

Mansfield Bio-Incubator – 241 Francis Avenue, Mansfield, MA 02048

__________________________________________________________________
Liquid chromatography-mass spectrometry (LC/MS) is a powerful analytical technique used for separation, identification, and quantification of both unknown and known compounds as well as to elucidate the structure and chemical properties of different molecules.

Join SCIEX & Phenomenex for a lunch and learn seminar. Come grab lunch and learn about LC-MS/MS technology from our team of experts!

Size does not matter — get answers to your challenging analytical questions for all molecule types                                                                                                                                                       

Matthew D. Stone, Ph.D. SCIEX, Biopharma Workflow Specialist

Click here to register for the event                                                  

View Event →
Entrepreneurship is not a one-person show; discover how to learn from peers.
Feb
9
10:00 AM10:00

Entrepreneurship is not a one-person show; discover how to learn from peers.

  • Mansfield Bio-Incubator, Inc. (map)
  • Google Calendar ICS

Starting a new business is not easy. It requires many skills and if you’re like most leaders, you know to avoid mistakes you must leverage your own skills while you learn from others.

Imagine what insights you could gain from the advice of highly talented people from diverse industries who are willing to share their knowledge and experience with you in your mission to create a sustainable, profitable business.

View Event →
Grand Opening of the Phase II Expansion and Open House Networking Event.
Oct
19
10:30 AM10:30
OPen House

Grand Opening of the Phase II Expansion and Open House Networking Event.

  • Mansfield Bio-Incubator, Inc. (map)
  • Google Calendar ICS

Join Us in Celebrating Southeastern Massachusetts’ Life Science Campus for Innovation and Innovators.

Mansfield Bio-Incubator, Bioinc, held Grand Opening of the Phase II expansion and Open House Networking Event

Wednesday, October 19, 2022

10:30 am to 2:30 pm

at Mansfield Bio-Incubator 241 Francis Avenue Mansfield, MA 02048




With over twenty (20) life science companies in place, we have room for a few more. Several of our member companies highlighted the benefits of being part of the growing South of Boston innovation ecosystem.

We invite you to view our portfolio companies at: https://www.bioinc.org/portfolio/

Come see for yourself how the Boston/Cambridge biotechnology supercluster now extends south of the city to form a Boston-Providence innovation corridor. The groundbreaking R&D activities going on within our laboratories are making a lasting contribution to the growth of the life science ecosystem in Southern New England. We are deepening the partnership with Wheaton College’s Diana Davis Spencer Entrepreneurship Center and other universities in the region. Our goal of creating a large campus consisting of R&D and manufacturing facilities is well underway.

Our Phase II expansion was made possible through Massachusetts Life Science Center’s Capital Program Grant and the matching contribution from a private foundation. Bioinc is celebrating the MLSC commitment to developing the life sciences across the Commonwealth, which includes the growing Southeastern Massachusetts life science cluster.

The new Phase II buildout’s key feature is a state-of-the-art BSL-2 laboratory space. The laboratory project is a renovation of an old glass factory and was built based on the modern concept of the lab design. Mansfield Bio-Incubator is a combination of open and private laboratory spaces seamlessly intertwined with meeting space to stimulate collaboration and creativity. We serve a variety of companies from a single founder start-up to a medium-size company ready to start product manufacturing.

In addition to the ribbon-cutting, the keynote program featured local, state, and federal elected officials, trade organizations, and local institutions of higher education. Several of Mansfield Bio-Incubator’s member companies presented their work.

Come see our world-class lab and hear how the Bio-incubator’s innovative startup companies are transforming the world with game-changing inventions in life science!

The grand opening coincided with the opening of a 700 square feet laboratory suite by Phenomenex, part of Danaher Corporation. The laboratory will have cutting-edge analytical instruments such as mass spectrometers, UHPLC, and sample preparation tools and technologies. The high-end equipment will be available to the member companies. Coupled with the decades of scientific expertise, this lab will serve as an indispensable asset to our current and future startups to turbocharge their projects in a synergistic fashion.



Agenda:

10:30 am: Registration, Networking and Refreshments

11:00 am: Keynote Program

11:45 am: Ribbon Cutting

12:00 noon: Lunch

12:45 pm: Company Presentations

1:45 pm-2:30 pm: Product Demonstrations, Continued Networking, and Facility Tours



Keynote Speakers:



Russ Yukhananov, PhD, President, and Alexander Margulis, PhD, COO, Mansfield Bio-Incubator

Jake Auchincloss, Massachusetts Representative

Margaret LaForest, Boston Regional Director at MA Office of Business Development at Commonwealth of Massachusetts

Paul Feeney, Massachusetts State Senator

Ben Bradford, Vice President of Economic Development and Workforce, Massachusetts Biotechnology Council

Kenn Turner, President and CEO, Massachusetts Life Sciences Center

Kevin Dumas, Town Manager, Town of Mansfield, MA

Imran Chowdhury, PhD , Diana Davis Spencer Chair of Social Entrepreneurship, Wheaton College




Presenting Companies:


Entrinsic Bioscience leverages proprietary biomapping and electrophysiology platform to identify, target, and validate combinations of amino acids as functional ingredients and APIs that deliver highly specific, efficient, and life -enhancing health benefits.

Emitech is developing a wearable bracelet for real-time and reliable narcotic detection that offers wireless communication with a user interface (smartphone, computer), with multiple sensors in the array to test for many narcotics (mostly synthetic).

Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, clinical research, governmental and academic laboratories.

Hilltop Bio is a veterinary biotech company developing innovative regenerative therapies focused on helping our four-legged friends reduce inflammation from injuries or disease. The company’s strategy is to identify key inflammatory diseases in companion animals and work to provide targeted regenerative therapies to help reduce inflammation and normalize damaged tissue function. Hilltop Bio has developed a strong pipeline of innovative therapies across many therapeutic classes, alongside cGMP, cGTP manufacturing capabilities, and a developing intellectual property portfolio.

3Daughters is a Woman’s Healthcare Company developing a new evolutionary intrauterine device (IUD) for contraception, based on physics, that conforms to a woman’s body. This revolutionary magnetic frameless IUD addresses the problems with the outdated T-shape design of current IUDs. These include significant insertion pain, expulsion, and uterine perforation along with the nuisance factor of the attached strings for IUD retrieval.

Beyond Biotech provides rAAV-related services to biological and medical researchers in universities, institutes, hospitals and biopharmaceutical companies. Our services include rAAV vector construction, rAAV-based shRNA and artificial miRNA design/construction/assay, rAAV packaging, and cell-based assay for gene therapy researchers.

Oncovolution is developing a new generation of platinum-based chemotherapies designed to increase tolerable dosages for patients.

Therabene is developing highly targeted PROTAC molecules to attack cancers, as well as viral and autoimmune diseases.

Neuronity is a biotech startup company developing First-in-Class immune therapy for age-related neurodegenerative diseases.

UpLevel Foods produce condiments that contain the most optimal nutrient density, and that’s important for the health and vitality of you and your family.

Turtle Health is bringing fertility care to your doorstep. They are developing the most accurate at-home fertility testing options to provide you with personalized, medically meaningful information to help you plan and manage your fertility journey, early and affordably.

Eighty Eight Pharma is developing two products, the Oppotoxy™ Bottle, and the CAREapace Container.

View Event →
Sep
28
4:30 PM16:30

MetroWest Life Science Network - 3rd Annual Fall Mixer

Join the MetroWest Life Sciences Network for a Fall Networking Event on Wednesday, September 28th from 4:30 PM - 7:30 PM!

About this event

Mix and mingle with life science professionals from MetroWest and beyond in the biotech industry. There will be free appetizers and drinks during this event.


MetroWest Life Science Network is raising funds for the MetroWest Life Science Network: Scholarship Fund. This scholarship is to assist students in eliminating financial barriers that they may face during their education. If unable to attend, please consider donating by clicking register. Even small donations add up!


We look forward to seeing you there!



RAINDATE: Thursday, September 29th, 2022

*Please note that this event will require proof of vaccination to ensure the safety of all.



View Event →
May
4
11:00 AM11:00

Know What You’re Getting Into: Breaking Down the Clinical Development Process

In-person Networking is Back! The Mansfield Bio-Incubator and Halloran Consulting invite you to a seminar and a networking event

 Wednesday, May 4, 2022

Know What You’re Getting Into: Breaking Down the Clinical Development Process

11:00 am-12:30 pm

at the Mansfield Bio-Incubator 241 Francis Avenue Mansfield, MA 02048

Directions: http://bit.ly/2y4EZe9

 

Description: 

The journey from discovery, through clinical trials and to commercialization is a long, challenging, and complex venture that ends in failure more often than not. Life science entrepreneurs can set themselves up for success by developing an understanding of the numerous regulatory and clinical hurdles that must be overcome.

Please join Halloran Consulting Group’s Matthew Cardinal, Vice President of Strategy & Program Leadership, for a presentation entitled “Know What You’re Getting Into: Breaking Down the Clinical Development Process”.

This presentation will teach the basics of the entire drug development process, from bench to bedside. A certain portion of the presentation is intended to be interactive, so all attendees are asked to come ready to share their stories, questions, and concerns.

 

Who should attend: Life science entrepreneurs.

Agenda:

 

11:00-11:05 PM: Introduction by Alex Margulis, Chief Operating Officer, Mansfield Bio-Incubator

 

11:05 PM-12:00 PM: Presentation and Q&A

 

12:00 PM-12:30 PM: Networking

 

About Halloran Consulting

Halloran Consulting Group is a life science consulting firm that provides strategic regulatory, quality, clinical, and organizational support to industry leaders and startup visionaries in the pharmaceutical, biotechnology, and medical device sectors. Our consultants are subject matter experts who deliver a tailored approach to each engagement, successfully propelling our clients to their next inflection point. We connect clients with our trusted industry partners to drive operational excellence and innovation throughout their organizations. Our aim is to support our clients, and the patients they serve.

Learn more at: https://www.hallorancg.com/

Additional Information

Please note: Mansfield Bio-Incubator is taking all appropriate precautions while also closely monitoring the latest public health guidance on COVID-19.

View Event →
Mar
16
2:00 PM14:00

SBIR Grant Writing Seminar

NCI SBIR workshop on the grant opportunities in biotech, pharma, medical devices, and other healthcare and life science areas.

About this Event

Mansfield Bio-Incubator is pleased to host The National Cancer Institute’s Small Business Innovation Research (NCI SBIR) Development Center. The center provides funding, networking, and mentoring assistance to small businesses with innovative cancer technology projects. On March 16, 2022, NCI SBIR Program staff, Xing-Jian Lou and Nancy Kamei, will be presenting funding opportunities and other commercialization resources for small businesses in biotech, pharma, medical devices, and other life science and healthcare areas. During the presentation, the topics covered will include:

• New and existing funding opportunities

• Investor and training programs such as the I-Corps at NIH entrepreneurship program

• Application tips and suggestions

Following the presentation, companies will have a chance to meet one-on-one with Xing-Jian Lou and Nancy Kamei to discuss their cancer technology project and funding eligibility. If you would like to be considered for a one-on-one meeting, please contact Alex Margulis by March 16, 2022 at alex.margulis@bioinc.org with a one-page summary of your company and technology.

Who should attend: Life science entrepreneurs/professionals who are looking for non-dilutive sources of money such as SBIR grants.

Agenda:

2:00 – 2:05 Housekeeping

2:05 – 2:10 Introduction to Mansfield Bio-Incubator

2:10 – 2:45 NCI SBIR Presentation

2:45 – 3:00 Audience Q&A

3:00 - 4:00 One-on-one Meetings


View Event →
Dec
7
to Dec 9

Venture Summit \ Virtual Connect

  • Mansfield Bio-Incubator, Inc. (map)
  • Google Calendar ICS

Mansfield Bio Incubator is pleased to sponsor and invite you to join us at Venture Summit \ Virtual Connect

Special offer: Register Now & Save $100 off (Use discount code “MBIOVIP")

 

 

Startups \ Investors \ Matchmaking

Venture Summit

          Virtual Connect

 

  December 7th - 9th 2021

 

* Call for Top Innovators Details below

 

Whether you’re a founder seeking capital and exposure, or an investor seeking new deals, Venture Summit \ Virtual Connect presented by youngStartup Ventures - is the event of the year you won't want to miss.

 

A highly productive 3-day venture conference, this exclusive summit is dedicated to showcasing early stage VCs, Corporate VCs and angel investors committed to funding venture backed, emerging and early stage Tech, Cleantech, Lifesciences, Healthcare, Fintech, and MedTech companies as well as showcasing over 100 Top Innovators.

 

Initial Lineup of Featured Investors include: Hamzeh Abdul-Hadi, Principal, Hikma Ventures | Egor Abramov, Principal, Fort Ross Ventures | Coleman Adams, Partner, Clean Energy Venture Group | Susan Akbarpour, Managing Partner, Candou Ventures | Faisal Al-Husry, Associate, Hikma Ventures | Abdullah Al-Shaksy, Co-Founder & CEO, Phaze Ventures | Alexey Alexanov, General Partner, Cabra VC | Jolene Anderson, Co-Founder & Managing Director, VectorPoint Ventures | Nick Arnold, Associate, HG Ventures | Aditya Asokan, Associate, Samsara BioCapital | Ashley Aydin, Principal, VamosVentures | Salman Azhar, Founding Partner & Managing Director, Azhar Private Equity | Jack Babbush, Associate, Centana Growth Partners | Yash Baid, Principal, 3one4 Capital | Assaf Barnea, CEO, Sanara Ventures | Jake Berec, Associate, Framework Venture Partners | Niresh Berinpanathan, Associate, Nextech Invest AG | Lisa Besserman, Managing Director, Expa | Raghu Bharat, Principal, Crédit Mutuel Equity | Steven Biesmans, Principal, UCB Ventures | Wade Bitaraf, Founder, Energy & Sustainability, Plug and Play Ventures | Robert Blom, Senior Investment Manager, Eneco Ventures | Jason Blumberg, Managing Director, Energy Foundry | Franziska Bossart, Group VP, ABB Technology Ventures | Sara Brand, Founding General Partner, True Wealth Ventures | Hilla Brenner, Managing Director, Techstars | Rebecca Canter, Associate, SV Health - Dementia Discovery Fund | Christy Cardenas, Managing Partner, Grit Ventures | Kathryn Cartini, Co-founder & Partner, Chloe Capital | Matt Caspari, Managing Partner, Strawberry Creek Ventures / Alumni Ventures | Caroline Casson, Partner, VitalizeVC | Julie Castro Abrams, General Partner, How Women Invest | Sara Chamberlain, Managing Director, Energy Foundry | Iris Chan, Senior Partner, Mighty Capital | Ray Chan, Venture Partner, K5 Ventures | Eloise Charreyron, Principal, Zipdragon Ventures | Bonnie Chau, Investment Manager, BCF Ventures | Sean Cheng, Partner, Philips Ventures | Stephanie Cherrin, Principal, Porsche Ventures | Arjun Chirumamilla, Investor, McKesson Ventures | Carl Choi, Principal, Solasta Ventures | Andrew Clapp, Managing Partner, Brightside Venture Capital | Brett Clarke, Analyst, VoLo Earth Ventures | Conor Clifford, Principal, Future Energy Ventures | Bruce Cohen, Venture Partner, Xeraya Capital | Michael Cohen, Investment Director, SAIC Capital | Michael Connolly, Founder / CEO, Atlas Digital Partners | Marina Cortes, VP, Hike Ventures | Pascal Croak, Associate, Bain Capital Ventures | Jenieri Cyrus, Associate, Urban Innovation Fund | Danielle D’Agostaro, Partner, WV Ventures | Sam Das, Managing Director, CMFG Ventures | Jessica Davis, Senior Associate, Dynamk Capital | Vivian de Ruijter, Associate, Intuitive Ventures | Alex Delbridge, Associate, Omega Funds | Ajay Dharia, Principal, Med Tech Venture Partners | Mike Donnelly, Partner, Ibex Investors | Tahira Dosani, Managing Partner, resilienceVC | Pascal Drouin, Partner, Cycle Capital Management | Lara Druyan, Managing Director, Silicon Valley Data Capital | Jeff Ebel, President, Midwest Wealth Ventures | Denis Efremov, Principal, Fort Ross Ventures | Zach Eisen, Principal, Cleveland Clinic Ventures | Bettina Ernst, Director, BERNINA BioInvest | Raphael Fässler, Investment Associate, Swiss Post Ventures | Rachael Ferm, Investor, Alumni Ventures | Mark Fields, Partner, Alsop Louie Partners | Alex Freed, Principal, Schematic Ventures | Mike Freeman, General Partner & CEO, Innosphere Ventures | Christian Frey, Data Analyst, Link Ventures | David Friedman, Orange County Chapter President, Tech Coast Angels - OC | Itschak Friedman, Partner, LionBird | Stan Fung, Managing Director, FarSight Ventures | Elena Gantvarg, Principal, Flint Capital | Daisy Garcia, Senior Investment Analyst, JetBlue Technology Ventures | Selma Gasc, Associate, 360 Capital | Moien Giashi, Associate, Green Sky Capital | Žilvinas Giedraitis, Investment Analyst, Contrarian Ventures | Sonia Gokhale, Co-Founder & General Partner, VentureSouq | Dani Goldsher, CFO, Triventures | Jacqueline Goodman, Senior Analyst, SJF Ventures | Michelle Gouveia, Vice President, Sandbox Insurtech Ventures | Ed Greer, Tech Scout Corporate Ventures, Dow Chemical | Matthew Gura, Associate, Baird Capital | Melissa Guzy, Co-Founder and Managing Partner, Arbor Ventures | Mickias Hailu, Associate, Portage Ventures | Thomas Henry, Co-Founder & COO, Eunike Ventures | Dennis Hens, Sr. Investment Manager, Global Core Medical | Itai Hoffman, Senior Associate, Hanaco Ventures | Charlton Hook, Investment Executive, Illuminate Financial | Noelle Hutchins, Associate, Omega Funds | Ty Jackson, Associate, SeventySix Capital | Abhinav Jain, Vice President, CSL Capital Management | Ben Jen, Managing Director, Ben Jen Holdings | Benjamin Jen, Founder & Managing Partner, GRC Funds | Jonathan Jennings, Senior Analyst, Framework Venture Partners | Ross Julian, Associate, InnovaHealth Partners | Jotthe Kannappan, Associate, Intuitive Ventures | Mike Katz, Managing Director, Benson Capital Partners | Irving Kau, Managing Partner, Elementz Ventures | James Kibbie, Analyst, DRW Venture Capital | Andrew Kirima, Hard Tech Analyst, Cantos Ventures | Kyle Kling, Head of US Investments, MDI Ventures | Howard Ko, Partner, Morpheus Ventures | Kim Kolt, Founder & President, For Good Ventures | Dieter Kondek, Co-Founder & Advisor, Global Blockchain Ventures (GBV) | Yana Kostadinova, Early-stage VC, Crosspring | David Kunz, Managing Director & General Partner, Hall Venture Partners | John-Paul Lake, Co-Founder & Managing Partner, Kern Venture Group | Vijay Lakshman, Managing Director, Mindgrub Ventures | Liron Langer, Chief Investment Officer, Nielsen innovate Fund | Chris Langford, Partner, IDEA Fund Partners | Zachary Leach, Associate, Catalyst Health Ventures | Victoria Lebegue, Associate, Concrete Ventures | Andrew Lee, Principal, Antler | Eric Lee, Vice President, Aligned Climate Capital | James Lee, Investment Associate Director, Photonfund | Lizzie Lee, Senior Director, McKesson Ventures | Ephraim Lindenbaum, Managing Director, Advance Ventures | Charles Ling, Investment Director, Foothill Ventures | Darwin Ling, Founder and General Partner, Good AI Capital | Martyn Lomax, Director of Engineering, Juniper Ventures | Denise Longley, Managing Partner, Longley Capital | Antonio Luck, Managing Partner, MatterScale Ventures | Kunal Lunawat, General Partner, Agya Ventures | Ruchit Majmudar, Senior Analyst, JetBlue Technology Ventures | David Mandel, Managing Partner, Emerging Ventures | Maulik Mehta, Venture Associate, Arc Ventures | Matt Melymuka, Co-Founder & Partner, PeakSpan Capital | David Mendez, Managing Partner, Good Growth Capital | Timothy Mills, Managing Director, Sanderling Ventures | Wanli Min, Founder and CEO, North Summit Capital | Peter Mintun, Associate, ARCH Venture Partners | Cole Mora, Analyst, Struck Capital | Anita Motwani, Founder, Sarla Ventures | Mattia Mrvosevic, Partner, Eterna Capital | Suraj Mudichintala, Associate, Arboretum Ventures | Shohei Nagatsuka, Investment Team, McRock Capital | Subbu Nambi, Director of Life Sciences Research, General Atlantic | Chris Neil, Co-Founder & Head, Maxim Ventures | Maurice Ng, General Partner, Tings Capital Management, LP | Mika Nishimura, Operational Partner, Gilde Healthcare | Paul Nolde, Managing Director, Riverflow Growth Fund | Samir Novruzov, Venture Analyst, I2BF Global Ventures | Chidi Nwankpa, Senior Associate, Gore Range Capital | Matt O’Rourke, Principal, WindSail Capital Group | Graham Ober, Vice President, Revolution | Gilbert Ohana, Managing Partner, FinTLV Ventures | Gail Page, Venture Partner, Turret Capital Management | Chris Park, Investment Director, UL Ventures | John Parker, Founder and Managing Director, Springhood Ventures | Luca Parolari, Senior Associate, DCVC Bio | Giorgio Pastarini, Investment Analyst, P101 | Cameron Peterkin, Associate, BCI Technology Investments | Damien Petty, Partner, Morpheus Ventures | Vincent Pichon, Investment Director, ENGIE New Ventures | Flavio Pripas, Investor, Redpoint eventures | Gayathri Radhakrishnan, Director, Micron Ventures | Suraj Rajwani, Managing Partner, DoubleRock | Mark Ralph, Executive Director, Boehringer Ingelheim Venture Fund | Gowri Raman, Director, Venture Capital, Medtronic | Ashley Ramirez, Vice President, Halogen Ventures | Suman Rao, Associate, Lumira Ventures | Catherine Rhee, Associate, Legendary Ventures | Jordan Rohrlich, Associate, Activate Capital | Bernard-Louis Roques, General Partner & co-Founder, Truffle Capital | Rob Rosenberg, Partner, Prolog Ventures | Mario Ruiz, Co-Founder and Partner, Infinity Ventures | Jesús Salas, Senior Associate, Slauson & Co. | Matt Saunders, Co-Founder & Partner, Fastbreak Ventures | Michael Savage, Executive Coach & Partner, Prime Movers Lab | Mark Schneider, Chairman, New York Angels | Mike Schulte, Venture Partner, Great North Ventures | Kate Seledets, Investment Team, 500 Startups | Parikshit Sharma, Principal, IndieBio | Shantnu Sharma, Managing Director, AMD Ventures | Emily Shirley, VC Analyst, Great North Ventures | Advait Shroff, Analyst, BluePointe Ventures | Michael Sienko, GP, Carbon Seed | Dr Pooja Sikka, Partner, Octopus Ventures | Emma Silverman, Principal, TMV | Blair Simpson, Principal, Frontier Venture Capital | Vinay Singh, Managing Director, Anthemis | Shounok Sinha, Investment Principal, Constellation Technology Ventures | Alix Sipahi, Analyst, DSM Venturing | Pierre Socha, Partner, Amadeus Capital | Simon Sokol, Investment Associate, Relay Ventures | Catello Somma, Associate, TVM Capital | Peter Sopher, Manager of Investments & Portfolio Support, Clean Energy Ventures | Kumar Sripadam, General Partner, Elevate Capital | Priscilla Sugianto, Senior Associate, Vivo Capital | Sebastian Sulma, Scout and Head Analyst, DEPO Ventures | Rajesh Swaminathan, Partner, Khosla Ventures | Daniel Teo, Managing Partner, Hunniwell Lake Ventures | Lucas Timberlake, Partner, Fintech Ventures Fund | David Uffer, Senior Partner & VP of MedTech, Alira Health | Mark Vreeke, Co-Founder, Chemical Angel Network | Jordan Wahbeh, Managing Partner, SV Venture Group | Christy Wang, Investor, Newfund Capital | Paul Weinstein, General Partner, Azure Capital Partners | Henry Wong, Founder & Managing Director, Diamond TechVentures | Minjia Wu, Principal, SOSV | Zach Yoshor, Analyst, ADvantage Sports Tech Fund | Tony Zhu, Venture Associate, Clean Energy Trust and many more...

 

Special Offer:

Mansfield Bio Incubator has made special arrangement for our network to receive a special discount of $100 off. This conference will be attended by the best people in the industry. Please register early to avoid disappointment.  (Use promo code "MBIOVIP”)

 

In addition to providing access to leading Investors, the conference will feature more than 100 pre-screened venture backed, emerging and early stage companies seeking capital, and hardcore networking. 

 

 

Call for TOP INNOVATORS!

Get Noticed > Get Funded > Grow Faster

 

A select group of more than 100 Top Innovators will be chosen to present their breakthrough investment opportunities to an exclusive audience of Venture Capitalists, Corporate Investors, Private Investors, Investment Bankers, and Strategic Partners.

 

Apply to Present / Nominate a company:

For more information or to be considered for one of the Top Innovator slots click here

 

View Event →
Sep
15
2:00 PM14:00

SBIR Grant Writing Seminar

NCI SBIR workshop on the grant opportunities in biotech, pharma, medical devices, and other healthcare and life science areas.

About this Event

Mansfield Bio-Incubator is pleased to host The National Cancer Institute’s Small Business Innovation Research (NCI SBIR) Development Center. The center provides funding, networking, and mentoring assistance to small businesses with innovative cancer technology projects. On September 15, 2021, NCI SBIR Program staff, Xing-Jian Lou and Nancy Kamei, will be presenting funding opportunities and other commercialization resources for small businesses in biotech, pharma, medical devices, and other life science and healthcare areas. During the presentation, the topics covered will include:

• New and existing funding opportunities

• Investor and training programs such as the I-Corps at NIH entrepreneurship program

• Application tips and suggestions

Following the presentation, companies will have a chance to meet one-on-one with Xing-Jian Lou and Nancy Kamei to discuss their cancer technology project and funding eligibility. If you would like to be considered for a one-on-one meeting, please contact Alex Margulis by September 13 at alex.margulis@bioinc.org with a one-page summary of your company and technology.

Who should attend: Life science entrepreneurs/professionals who are looking for non-dilutive sources of money such as SBIR grants.

Agenda:

2:00 – 2:05 Housekeeping

2:05 – 2:10 Introduction to Mansfield Bio-Incubator

2:10 – 2:45 NCI SBIR Presentation

2:45 – 3:00 Audience Q&A

3:00 - 4:00 One-on-one Meetings


View Event →
Jun
17
to Jun 18

Your Path to Growth in Life Sciences: Leveraging Resources & Avoiding Pitfalls

  • Mansfield Bio-Incubator, Inc. (map)
  • Google Calendar ICS

In a state offering world-renowned universities and research hospitals, it is no surprise that Massachusetts is a global leader in the life sciences industry, boasting one of the world's largest life sciences clusters attracting companies from around the world. Many businesses emerge from the scientific advancements developed in partnership with these institutions, but what assistance is available to help these businesses grow, both domestically and internationally? What types of funding are available and how can they be secured? What do business owners need to know when developing their workforce?  

Join us to learn about resources for growing your business while mitigating costly risk. Learn about determining financial viability, obtaining financing, and grant opportunities. Additional topics include controls on foreign access to U.S. technology with regard to hiring and investment, and diversifying into foreign markets. 

An introduction will be provided by Alexander Margulis, COO of the Mansfield Bio-Incubator. Speakers include:  

  • Nancy Lowd, Senior Business Advisor — Massachusetts Small Business Development Center (MSBDC) Network

  • Kathleen Newell, Trade Compliance Manager — Massachusetts Export Center, MSBDC Network

Date: Thursday, June 17, 2021
Time: 12:00 – 1:00 p.m. EST
Location: Webinar
Cost: No Charge
Contact: Kathleen Newell at the Massachusetts Export Center at kathleen.newell@massexport.org

View Event →
Mar
24
2:00 PM14:00

FDA and Emergency Use Authorization (EUA): Latest Updates for Startups.

Alira Health and Mansfield Bio-Incubator present, a U.S. Regulatory Update with Alira Health’s Mary McNamara-Cullinane, Senior VP Regulatory

About this Event

Join Alira Health’s Senior Vice President, Regulatory Affairs, Mary McNamara-Cullinane for a timely, interactive event, where Mary will give an update on the FDA, including a walkthrough of the EUA process, and best practices for submission development based on the latest FDA guidance.

Who should attend: Entrepreneurs in biotech, pharmaceuticals, medical devices, and other healthcare-related fields planning to approach FDA within the next year. Investors in these fields looking for guidance.

The presentation will be followed by a question-and-answer session.

About Alira Health

At Alira Health, our mission is to enable healthcare transformation. We support life sciences organizations with a lifecycle of services to uncover opportunities, accelerate innovation, and improve outcomes for patients around the world.

And we don’t just advise, we innovate right alongside our clients through Alira Health Ventures: a state-of-the-art incubator space where new products are researched, developed, and taken to market.

Our team helps simplify the complicated journey that is the healthcare and life sciences product and corporate lifecycles — so your team can innovate, grow, and achieve success at every turn.

To learn more, visit www.alirahealth.com

About Mansfield Bio-Incubator

Mansfield Bio-Incubator is a non-profit biotech, pharma, life science, and medical device business incubator facility. Our mission is to facilitate and assist the creation, growth, and success of the next generation of biotech, pharma, life science, and medical device companies. We were created to nurture entrepreneurial and economic development in the community. We aim to do this by maintaining affordable lab and office space and making cutting-edge technology, services, training, mentoring, and a network of professional advisors available to small biotechnology companies and healthcare-related start-ups. Furthermore, our member companies are eligible for the newly-established MLSC Seed Fund Program.

To learn more, visit https://www.masslifesciences.com/programs/seedfund/

Mansfield Bio-Incubator is a proud recipient of Massachusetts Life Science Center's Open Capital Program Grant and is planning to expand by 15,000 square feet by the end of 2021. The newly-built space will include private laboratory suites and more shared lab space and state-of-the art equipment.

To learn more, visit https://www.bioinc.org/upcoming-expansion

Interested in becoming a member, sponsor, partner , or mentor?

Visit https://www.bioinc.org/

View Event →
Feb
24
2:00 PM14:00

SBIR Grant Writing Seminar

NCI SBIR workshop on the grant opportunities in biotech, pharma, medical devices, and other healthcare and life science areas.

About this Event

Mansfield Bio-Incubator is pleased to host The National Cancer Institute’s Small Business Innovation Research (NCI SBIR) Development Center. The center provides funding, networking, and mentoring assistance to small businesses with innovative cancer technology projects. On February 24 2021, NCI SBIR Program staff, Xing-Jian Lou and Nancy Kamei, will be presenting funding opportunities and other commercialization resources for small businesses in biotech, pharma, medical devices, and other life science and healthcare areas. During the presentation, the topics covered will include:

• New and existing funding opportunities

• Investor and training programs such as the I-Corps at NIH entrepreneurship program

• Application tips and suggestions

Following the presentation, companies will have a chance to meet one-on-one with Xing-Jian Lou and Nancy Kamei to discuss their cancer technology project and funding eligibility. If you would like to be considered for a one-on-one meeting, please contact Alex Margulis by February 23 at alex.margulis@bioinc.org with a one-page summary of your company and technology.

Who should attend: Life science entrepreneurs/professionals who are looking for non-dilutive sources of money such as SBIR grants.

Agenda:

2:00 – 2:05 Housekeeping

2:05 – 2:10 Introduction to Mansfield Bio-Incubator

2:10 – 2:45 NCI SBIR Presentation

2:45 – 3:00 Audience Q&A

3:00 - 4:00 One-on-one Meetings


View Event →
Aug
4
11:00 AM11:00

NEW Date: Bring your work to life with Allevi 3D bioprinters. What will you build?

The Mansfield Bio-Incubator and Allevi invite you to an online event

Tuesday, August 4, 2020  

Bring your work to life with Allevi 3D bioprinters: What will you build?

11:00 am- 12 noon

 ONLINE EVENT

Description: 

Allevi creates tools and solutions to design, engineer and build with life. Our 3D bioprinters, Bioprint software and bioinks are used by leading researchers around the world to find solutions to humanity’s most difficult problems. 

We created our desktop 3D bioprinters to be the most versatile, powerful and easy-to-use bioprinters on the market. Our syringe-based bioprinters enable users to experiment with any biomaterial, work with any cell line and print in any geometry. Our bioprinters and Bioprint Software empower novice and expert 3D bioprinting users alike to quickly and easily achieve their goals.

We believe everyone has the potential to change the course of medicine for the better. What will you build?

Who should attend: Life science entrepreneurs and anyone else interested in 3D Bioprinting.

 
Come see the printer in action!

View Event →
Jun
17
12:00 PM12:00

Crowdfunding a startup; A few options.

  • Zoom link will be provided for the registrants (map)
  • Google Calendar ICS

Description:

In recent years, crowdfunding emerged as an alternative source of startup funds generating almost $10B of seed funds. Host, Mark Norige, will review the basics of crowdfunding and moderate a discussion with experts on similarities of alternative and traditional capital investment approaches. Attend to learn how popular crowdfunding options work and if any are right for your business. Who should attend: early-stage entrepreneurs, particularly in life sciences, biotech, biopharma, medical devices, and healthcare.

Mark Norige 1.gif

Host Mark Norige is the Principal and CEO of the Board Forum, a successful CEO peer advisory firm and Chief Executive Manager of CHP LLC, an early stage medicinal products company. He also advises early-stage businesses and is an Advisory Board member of Mansfield Bio-Incubator. Mark brings 30 plus years of business leadership experience helping small to mid-size companies grow revenue and profits by conducting analysis of their business and guides them to develop strategies and execution plans to achieve their desired results. Prior to the Board Forum, Mark worked in a variety of leadership roles for both early-stage and Fortune 300 global companies including; Texas Instruments, Waters, Millipore, and Harvard Bioscience along with several early-stage investor backed firms. He is an adjunct professor in the graduate program in innovation and entrepreneurship at Brown University and earned his B.S. from UMASS and a Babson College MBA.

macomber.jpg

Guest Lily Macomber’s career spans various startups including non-profits and educational institutions such as MIT’s all in support of entrepreneurs and The Startup Network. She holds a BA from Providence College and is currently working on her MBA from Babson College. She currently responsible for business development at Netcapital, a fintech startup based in Boston. lily.macomber@netcapital.com

rimm.png

Guest Ilonna J. Rimm, MD, PhD, CFA advises Life Science CEO’s who are raising a Series A round of capital. She was instrumental in raising a $17M Series A financing for Immuneering Corporation in December of 2019. Dr. Rimm’s previous financing and investment experience includes: Trillium Asset Management, Lazard Capital Markets, Leerink Swann and Company, and Oxford Bioscience Partners. She has pharmaceutical company experience from Wyeth Pharmaceuticals. She is a Harvard-trained physician-scientist, with extensive experience in Oncology (Pediatric Hematology/Oncology) and Immunology. She worked both in leadership and in hands-on clinical and laboratory roles associated with the Dana-Farber Cancer Institute, Children’s Hospital and Harvard Medical School for two decades. ijrimm@expertise4innovation.com

View Event →
May
20
11:00 AM11:00

Mastering the Business of Life Science

Description:

As a highly educated science expert, you’re developing the next best medical breakthrough. Yet, great sicence is necessary but not sufficient to succeed in the long run. Mastering key business aspects is also critical. These include: raising money, managing that money, developing a commercialization plan, and thinking about global markets. Conversely, ignoring these essential business development tenets would likely set you up for failure.

Come hear a panel of experts speak on critical tips to master the business side of the science!

 

Learn about:

  • Critical components of an effective strategic plan

  • Due diligence to perform to align your science and business

  • Steps to improve your odds of success

  • How to raise the right money at the right time

  • Timing to consider global markets

  • The biggest mistakes and how to avoid them

Who should attend: Early-stage entrepreneurs, investors, and business development professionals in life sciences.

View Event →
Mar
18
11:30 AM11:30

Funding Best Practices - Corporate & IP

Description: 

The panel will discuss the funding trends in the Medtech industry, and the best Corporate and IP practices for early stage Medtech companies to secure funding. The topics will include:

  • Funding trends for early stage Medtech companies

  • 2019 v. 2018, 4th quarter 2019, 2020 outlook, etc.

  • Differences for various medical technologies (biotech, devices, healthcare IT, services, etc.) and stages (early vs. late)

  • 2019 Exits – M&A and IPO trends

  • Best IP and Corporate practices

Who should attend: Life science entrepreneurs, investors, and associated service providers.

 

Speakers: 

Roman Fayerberg-Greenberg Traurig, Shareholder & Patent Attorney
Emily Ladd-Kravitz-Greenberg Traurig, Shareholder and Corporate Attorney
TBA

 

About Greenberg Traurig, LLP: Greenberg Traurig, LLP (GT) has approximately 2100 attorneys in 41 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100.

Web: https:// www.gtlaw.com

View Event →
Feb
26
11:30 AM11:30

Investor Deck: Maximizing Your Chances of Success.

The Mansfield Bio-Incubator and Alira Health invite you to a seminar and a networking event 

Wednesday, February 26, 2020   

Investor Deck: Maximizing Your Chances of Success.

11:30 am- 1:30 pm

at the Mansfield Bio-Incubator
241 Francis Avenue
Mansfield, MA 02048

Directions: http://bit.ly/2y4EZe9

Description:

An Investor Deck is a critical tool for every life sciences organization to showcase their value to prospective investors, and in this interactive session, we invite an expert panel from Alira Health to talk through critical deck components and discuss how to engage, invest, and maximize value and different inflection points of your growth. The panel will include insights from a regulatory, clinical, strategic, and investor perspective, and will provide you with information and ideas for maximizing value and every stage of your development.

View Event →
Jan
28
9:00 AM09:00

The R&D Tax Credit for Small Businesses

Is your business missing out on this additional source of cash flow?

Small businesses and startups comprise the vast majority of companies in the US, consistently stimulating the economy through growth and innovation.  However, many of these companies are not aware of all the financial incentives available to them, including the Research and Development (R&D) Tax Credit.

Leyton is pleased to host this webinar in partnership with the ACTION Innovation Network to share how companies in the network can increase their cash flow through the R&D Tax Credit.

This webinar will cover:

  • How can the R&D Credit provide additional cash flow?

    • An Introduction to the R&D Tax Credit

    • An Introduction to the Payroll Tax Credit for startups

      • Is my business eligible? What is a Qualified Small Business?

  • Who is eligible to claim?

    • 4 Part Test

    • Industries

  • How do I claim this credit for my company’s R&D?

    • Best practices

  • Leyton with contact information + Q&A

This webinar will be presented by Leyton, a global R&D Tax Credit consulting firm.  Their team of highly experienced scientists, engineers, tax consultants and tax attorneys implement strategies to claim the R&D Tax Credit, ensuring maximum eligible financial return without impacting a company’s core business.

View Event →
Jan
27
7:00 PM19:00

JP Morgan Conference Review and Winter Social with Lightning Pitches

JP Morgan Conference Review and Winter Social with Lightning Pitches

Make new connections and hear the latest industry updates at our Tenth Anniversary and 6th Annual Winter Networking Social with Lightning Pitches!

J.P. Morgan Conference Review: We are excited to announce our keynote speaker, Bruce Robertson, Managing Director H.I.G. Capital. Just returning from the 2020 J.P. Morgan Healthcare Conference, Bruce will provide our members with a recap from one of the most influential healthcare investment conferences. Find out what the experts are saying about the overall market, future of drug pricing, regulatory environment and capital markets.

Lightning Pitches: During the lighting pitch segment, we will learn more about members whose companies provide valuable services that enable the growth of our healthtech ecosystem. Each pitching company will have 1 minute to impress us with their value proposition. There will also be plenty of opportunity to network with the companies and fellow members.

View Event →
Jan
16
6:00 PM18:00

Think, act and grow rich. Free seminar shares entrepreneur hacks.

Are you thinking about and doing the right things to make your business the most successful it can be?

About this Event

A complimentary workshop entitled “Think, act and grow rich. Entrepreneur hacks” is set for Thursday, January 16, 2020 from 6:00-7:30PM at the Mansfield Bio Incubator, 241 Francis Avenue, Mansfield, MA.

The workshop will explore four strategies for thinking critically about your business to help it to grow and thrive.

• What is your next best move? Where is your business on the business life cycle and what are the implications for its future success?

• Are you focused? How do you keep your focus on your vision, goals, projects and actions?

• Are your employees your biggest asset? Do your employees embrace change? If not, what is causing their reluctance and how can you change it?

• What makes your business different? Knowing what makes you different and finding ways to exploit the differences can dramatically improve performance.

The workshop will be led by Dominic Grew and Lisa Levesque who are certified business coaches and trainers with FocalPoint International Coaching & training.

Grew has more than 25 years of proven business development experience, building, growing and leading change, primarily in financial service companies. Dominic earned a Masters in Management from Cambridge College. Dominic is originally from Belfast , Northern Ireland, but today calls Sharon, MA home, where he lives with his wife and three children.

Levesque is a leader in business productivity and has helped Fortune 500 companies reduce costs while increasing revenue and gaining market share. Lisa is a graduate of Boston College, with a degree in Accounting and earned an MBA from Babson College. She resides in Foxboro, MA with her husband, two daughters and two dogs.

For more information, please contact Steven V. Dubin at SDubin@MyPinnacleNetwork.com or 781-582-1061.

View Event →
Jan
15
11:45 AM11:45

POSTPONED (Date TBD): Startup Essentials: Reimbursement Analysis and Planning

Description: 

A clear-eyed understanding of the reimbursement landscape is essential to any life science startup’s ability to effectively pursue financing, product development and commercialization. A fully integrated clinical, regulatory and reimbursement plan, responsive to the obstacles and opportunities presented by a rapidly evolving healthcare reimbursement system, can optimize resource utilization and time to revenue and can dramatically change the odds of success.

Join Ed Berger, Principal and Founder of reimbursement consultancy Larchmont Strategic Advisors, for an exploration of the fundamental elements of the reimbursement landscape and practical guidance on how and when to address reimbursement strategy issues for your diagnostic, therapeutic or medtech innovation.

If you want to become a successful life science entrepreneur, it is essential to learn early on how the key stakeholders are going to pay for your product, no matter how great it is.

Who should attend: Early-stage entrepreneurs in life sciences.

View Event →